First published online April 5, 2007
Stem Cells
Vol. 25 No.
7
July 2007, pp.
1645
-1653
doi:10.1634/stemcells.2006-0624; www.StemCells.com
© 2007 AlphaMed Press
Spheres Isolated from 9L Gliosarcoma Rat Cell Line Possess Chemoresistant and Aggressive Cancer Stem-Like Cells
Ali Jourabchi Ghodsa,
Dwain Irvina,
Gentao Liua,
Xiangpeng Yuana,
Iman R. Abdulkadira,
Patrizia Tunicia,
Bindu Kondaa,
Sebastian Wachsmann-Hogiub,
Keith L. Blacka,
John S. Yua
aMaxine Dunitz Neurosurgical Institute, Los Angeles, California, USA;
bDepartment of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA
Key Words. Spheres • Monolayer • Mitogens • Cancer stem-like cells • Glioma
Correspondence: John S. Yu, M.D., 8631 West Third Street, Suite 800E, Los Angeles, California 90048, USA. Telephone: 310-423-0845; Fax: 310-423-0810; e-mail: Yuj{at}cshs.org
Received October 2, 2006;
accepted for publication March 29, 2007.
First published online in STEM CELLS EXPRESS April 5, 2007.
The rat 9L gliosarcoma is a widely used syngeneic rat brain tumor model that closely simulates glioblastoma multiforme when implanted in vivo. In this study, we sought to isolate and characterize a subgroup of cancer stem-like cells (CSLCs) from the 9L gliosarcoma cell line, which may represent the tumor-initiating subpopulation of cells. We demonstrate that these CSLCs form clonal-derived spheres in media devoid of serum supplemented with the mitogens epidermal growth factor and basic fibroblast growth factor, express the NSC markers Nestin and Sox2, self-renew, and differentiate into neuron-like and glial cells in vitro. More importantly, these cells can propagate and recapitulate tumors when implanted into the brain of syngeneic Fisher rats, and they display a more aggressive course compared with 9L gliosarcoma cells grown in monolayer cultures devoid of mitogens. Furthermore, we compare the chemosensitivity and proliferation rate of 9L gliosarcoma cells grown as a monolayer to those of cells grown as floating spheres and show that the sphere-generated cells have a lower proliferation rate, are more chemoresistant, and express several antiapoptosis and drug-related genes, which may prove to have important clinical implications.
Disclosure of potential conflicts of interest is found at the end of this article.

Copyright © 2007 by AlphaMed Press.